Shihui Mao

533 total citations · 1 hit paper
23 papers, 311 citations indexed

About

Shihui Mao is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Shihui Mao has authored 23 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Shihui Mao's work include Acute Myeloid Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Shihui Mao is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Shihui Mao collaborates with scholars based in China and Italy. Shihui Mao's co-authors include Lisheng Chu, Xiaowei Hu, Baojian Yu, Weifeng Jiang, Lin Li, Jie Jin, Xiangjie Lin, Wenwen Wei, Wenle Ye and Fenglin Li and has published in prestigious journals such as Blood, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Shihui Mao

21 papers receiving 310 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway

2023 122 citations Lin Li, Weifeng Jiang et al. Biomedicine & Pharmacotherapy profile →

Peers

Shihui Mao

HEMAT

NEURO

IMMUN

Yating Chong China

Ramóna Pap Hungary

Anqi Zhang China

Xuliang Wang China

Feng Xiao China

Yingyu Zhang China

Xiangjun Zeng China

Feng-Cheng Liu Taiwan

Eddy Himpe Belgium

Yating Chong China

Shihui Mao

128 ×0.8

44 ×0.6

36 ×0.7

HEMAT

17 ×0.3

NEURO

30 ×0.8

IMMUN

Citations per year, relative to Shihui Mao Shihui Mao (= 1×) peers Yating Chong

Countries citing papers authored by Shihui Mao

Since Specialization

Citations

This map shows the geographic impact of Shihui Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shihui Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shihui Mao more than expected).

Fields of papers citing papers by Shihui Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shihui Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shihui Mao. The network helps show where Shihui Mao may publish in the future.

Co-authorship network of co-authors of Shihui Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Shihui Mao. A scholar is included among the top collaborators of Shihui Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shihui Mao. Shihui Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yong, et al.. (2025). LRP8 inhibits bladder cancer cell ferroptosis by activating the Wnt/β-catenin-SCD1 positive feedback loop. Human Molecular Genetics. 34(10). 843–851.

Mao, Shihui, et al.. (2025). Extracellular vesicles enriched with miR-486 from Tetramethylpyrazine-preconditioned bone marrow mesenchymal stem cells promote microglia/macrophage M2 polarization and enhance neurogenesis in rats with ischemic stroke. Stem Cell Research & Therapy. 16(1). 455–455.

Li, Lin, Weifeng Jiang, Shihui Mao, et al.. (2025). Artemisinin alleviates ischemic stroke injury and promotes neurogenesis through PPARγ-mediated M2 polarization of microglia. Phytomedicine. 142. 156769–156769. 2 indexed citations

Mao, Shihui, Xiaowei Hu, Li Lin, et al.. (2024). Exosomal miR-486 derived from bone marrow mesenchymal stem cells promotes angiogenesis following cerebral ischemic injury by regulating the PTEN/Akt pathway. Scientific Reports. 14(1). 18086–18086. 13 indexed citations

Pan, Jiajia, Yungui Wang, Shujuan Huang, et al.. (2024). High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of Molecular Medicine. 102(3). 415–433. 5 indexed citations

Zhao, Yanchun, Qian Yu, Wenwen Wei, et al.. (2024). m⁶A‐dependent upregulation of DDX21 by super‐enhancer‐driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clinical and Translational Medicine. 14(4). e1628–e1628. 13 indexed citations

Ye, Wenle, Xin Huang, Jiansong Huang, et al.. (2023). Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. British Journal of Haematology. 202(3). 566–577. 10 indexed citations

Mao, Shihui, Qian Yu, Wenwen Wei, et al.. (2023). FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of Hematology. 102(3). 583–595. 7 indexed citations

Mao, Shihui, Jiajia Pan, Wenwen Wei, et al.. (2023). CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML. Cancer Biomarkers. 37(3). 133–145. 4 indexed citations

10.

Li, Lin, Weifeng Jiang, Baojian Yu, et al.. (2023). Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 168. 115653–115653. 122 indexed citations breakdown →

11.

Li, Fenglin, Qing Ling, Ying Chen, et al.. (2023). Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer Medicine. 12(7). 8319–8330. 8 indexed citations

12.

Li, Fenglin, Wenle Ye, Wenwen Wei, et al.. (2023). Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. Journal of Translational Medicine. 21(1). 115–115. 9 indexed citations

13.

Wei, Wenwen, Jiajia Pan, Jinghan Wang, et al.. (2023). circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis. Molecular Carcinogenesis. 62(10). 1546–1562. 4 indexed citations

14.

Wei, Wenwen, Shujuan Huang, Qing Ling, et al.. (2022). Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia. Journal of Translational Medicine. 20(1). 299–299. 12 indexed citations

15.

Yu, Qian, Xiang Zhang, Shihui Mao, et al.. (2022). ACC010 , a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ ITD . Molecular Oncology. 17(7). 1402–1418. 4 indexed citations

16.

Li, Fenglin, Xiang Zhang, Shihui Mao, et al.. (2021). MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway. EBioMedicine. 69. 103441–103441. 10 indexed citations

17.

Lin, Xiangjie, Jinghan Wang, Xin Huang, et al.. (2021). Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study. Aging. 13(7). 10468–10489. 35 indexed citations

18.

Mao, Shihui, Jiajia Pan, Fenglin Li, et al.. (2021). Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199. Journal of Translational Medicine. 19(1). 181–181. 29 indexed citations

19.

Mao, Shihui, Fenglin Li, Xia Li, et al.. (2019). A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells. Medical Oncology. 36(9). 77–77. 6 indexed citations

20.

Jin, Jie, Jiajia Pan, Yungui Wang, et al.. (2019). High Expression of BCAT1 promotes Acute Myeloid Leukemia Progression and Sensitize to PARP Inhibitor. Blood. 134(Supplement_1). 5041–5041. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact